Skip to content

To study the Effect of vaitaran basti and panchsam churna in amavata w.s.r. to rheumatoid arthritis

A clinical study to evaluate the efficacy of vaitaran basti and panchsam churna in amavata w.s.r. rheumatoid arthritis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024037
Enrollment
60
Registered
2020-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Vaitarana Vasti: 300ml of Vaitarana Vasti is given through anal route in kala Vasti schedule for 16 days inbetween anuvasan vasti of Eranda taila in a dose of 50ml is given Intervention

Sponsors

Government PG Ayurveda College and HospitalVaranasi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)The Subjects of Amavata diagnosed on the basis of signs & symptoms described in Ayurvedic classics & the criteria laid down by American Rheumatism Association 2010 will be selected for the study. 2)Subjects of age group 10-60 yrs & of either sex. (the ACR criteria define juvenile Rheumatoid Arthritis by age limit 3)Subjects fit for basti karma. 4)chronicity of

Exclusion criteria

Exclusion criteria: 1)Subjects associated with systemic illness such as Diabetes or Hypertension. 2)Patients who leave the treatment in between. 3)Subjects with cervical or Ankylosing spondylosis or S.L.E. 4)Subjects with anatomical deformity. 5)Subjects with pregnancy. 6)Patients of age group 60yrs. 7)chronicity of > 6 yrs.

Design outcomes

Primary

MeasureTime frame
Reduction in pain, Stiffness, Swelling of multiple joints , Anorexia, FeverTimepoint: 90 days

Secondary

MeasureTime frame
No recurrence of signs & symptomsTimepoint: 45 days

Countries

India

Contacts

Public ContactDr Manish Mishra

Sampurnanand Sanskrit university

manish.arnav@gmail.com9415896482

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026